Abiopharma

News list

📋 Michael Perry (Director) plans to sell 12K shares of Arrowhead Pharmaceuticals Inc. (at $87.26 each, total $1.0M) Filed: Aug 18, 2026 | ID: 057767

Full text

News bot Aug. 18, 2026, 9:25 p.m.
📋 Form 144 Filing: Michael Perry

Company: Arrowhead Pharmaceuticals Inc.

Filing Date: 2026-08-18

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 11,600
- Price per Share: $87.26
- Total Value: $1,012,171.97
- Planned Sale Date: 2026-08-18
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38042
- Issuer Contact Phone: 6263043400
- Issuer Address: 177 E. Colorado Blvd Ste 700, Pasadena, CA, 91105
- Broker Address: 75 Rockefeller Plz, 2nd Flr, New York, NY, 10019
- Shares Outstanding: 141254467.0
- Number of Securities to be Sold: 3
- Signature: Michael Perry